Available option
5mg / 1.2mL
Staff-prepared solution
- Strength
- 5mg / 1.2mL
- Format
- Staff-prepared solution
Bear Biotech catalogue
Ipamorelin
Growth-hormone secretagogue receptor research
- GHS receptor
- Pituitary response
- Endocrine research
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Available option
10mg / 1.2mL
Staff-prepared solution
- Strength
- 10mg / 1.2mL
- Format
- Staff-prepared solution
Available option
10mg
Lyophilised powder
- Strength
- 10mg
- Format
- Lyophilised powder
Research overview
What is Ipamorelin?
Ipamorelin is a selective growth-hormone secretagogue receptor research peptide used to study ghrelin-receptor signalling, pituitary GH release and endocrine response patterns. It attracts interest because its receptor profile differs from older GHRPs. Published evidence includes preclinical work and early human endocrine studies, not proof of a consumer performance effect.
Preclinical and early human endocrine research
Research focus
Key research areas
Ipamorelin research: selective ghrelin-receptor signalling
Ipamorelin is a synthetic pentapeptide studied at the ghrelin or growth-hormone-secretagogue receptor. Laboratory and early human studies measured receptor selectivity and endocrine endpoints. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- GHS receptor
- Pituitary response
- Endocrine research
Representative primary research
Representative research
An original pharmacology study examined ipamorelin in growth-hormone-secretagogue and pituitary-response models.
- Ipamorelin, the first selective growth hormone secretagogue ↗ Mechanistic research context only.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- Ipamorelin
- Research category
- Growth-hormone secretagogue receptor research
- Evidence position
- Preclinical and early human endocrine research
- Recorded formats
- Staff-prepared solution · Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
What makes Ipamorelin's receptor selectivity different from older GHRPs?
Ipamorelin is studied as a relatively selective growth-hormone secretagogue receptor agonist. Comparisons with older GHRPs examine whether that receptor profile produces a narrower endocrine-response pattern under the same experimental conditions.
Which endocrine endpoints are measured after Ipamorelin exposure?
Controlled studies measure the magnitude and time course of pituitary growth-hormone release, sometimes alongside other endocrine markers. Those endpoints describe a defined protocol rather than a general performance effect.
How far does the human evidence base for Ipamorelin extend?
Ipamorelin has preclinical evidence and limited early human endocrine research. The literature remains tied to the tested material, dose, protocol and measured endpoint; it does not establish a broad consumer outcome.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.